Sign in
4

Changes in Ownership

TELA Bio, Inc. Filed Acc 0001062993-22-005778

Chief Strategic Officer acquired 12,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Talmo Paul Chief Strategic Officer 2022-02-23 Grant or award +12,200 42,670 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Talmo Paul Chief Strategic Officer 2022-02-23 Grant or award · Stock Option (Right to Buy) +20,900 20,900 D: show line 2 in the form
Loading xslF345X03/form4.xml…